Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
BioSpace
Tue, 02/7/23 - 12:15 pm
Merck
Nectin Therapeutics
NTX1088
solid tumors
BMS returns $475M IL-12 oncology asset to Dragonfly’s pond
Fierce Biotech
Mon, 02/6/23 - 06:12 pm
Dragonfly Therapeutics
Bristol Myers Squibb
oncology
DF6002
solid tumors
J&J quietly punts a pair of early-stage bispecifics for solid tumors
Endpoints
Thu, 01/26/23 - 10:45 am
JNJ
bispecific antibodies
solid tumors
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
Stat
Sun, 01/22/23 - 01:05 pm
cancer
oncology
mesothelin
solid tumors
AbbVie inks Immunome solid tumor deal that could top $2.8B in biobucks
Fierce Biotech
Sun, 01/8/23 - 10:07 pm
AbbVie
Immunome
biobucks
solid tumors
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Fierce Biotech
Mon, 12/19/22 - 11:19 am
Sanofi
Innate Pharma
natural killer cells
solid tumors
Nectin's Series A Hits $25M as Investors Support New Target for Solid Tumors
BioSpace
Wed, 11/30/22 - 10:56 am
Nectin Therapeutics
funding
solid tumors
CatalYm Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors
BioSpace
Tue, 11/22/22 - 11:03 am
CatalYm
funding
visugromab
solid tumors
Teon treats first subject in Phase I/II solid tumor therapy trial
Clinical Trials Arena
Wed, 11/2/22 - 10:13 am
Teon Therapeutics
clinical trials
TT-816
solid tumors
Candel Pairs HSV Vectors with Carl June's CAR-T Cells in Solid Tumor Pact
BioSpace
Thu, 10/27/22 - 10:54 am
Candel Therapeutics
HSV vectors
CAR-T
solid tumors
Quadriga concludes patient enrolment in Phase I solid tumour trial
Clinical Trials Arena
Wed, 10/26/22 - 10:37 am
Quadriga BioSciences
clinical trials
QBS10072S
solid tumors
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
MedCity News
Fri, 10/21/22 - 10:42 am
Surge Therapeutics
Harvard
immunotherapy
solid tumors
funding
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
BioSpace
Mon, 10/17/22 - 10:51 am
Kineta
Merck
Keytruda
anti-VISTA
monoclonal antibodies
solid tumors
Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge
Fierce Biotech
Wed, 10/12/22 - 11:44 pm
Inceptor Bio
Avectas
solid tumors
CAR-T
cell therapy
BMS-backed Immatics' cell therapy shows early promise in small data set, prompting $110M offering
Fierce Biotech
Tue, 10/11/22 - 10:04 am
Bristol Myers Squibb
Immatics
cell therapy
clinical trials
solid tumors
Kling doses first subject in Phase Ib solid tumour antibody trial
Clinical Trials Arena
Fri, 09/30/22 - 11:02 am
Kling Biotherapeutics
KBA1412-101
solid tumors
clinical trials
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers
Businesswire
Thu, 09/29/22 - 09:59 am
Gamida Cell
solid tumors
blood cancers
omidubicel
Lilly’s Retevmo receives FDA approval to treat solid tumours
Pharmaceutical Business Review
Thu, 09/22/22 - 10:13 am
Eli Lilly
FDA
Retevmo
solid tumors
metastatic solid tumors
Fusion doses first subject in Phase I/II solid tumor therapy trial
Clinical Trials Arena
Tue, 08/30/22 - 11:53 am
Fusion Pharmaceuticals
solid tumors
clinical trials
FPI-1966
Regen BioPharma Develops Novel Means of Using CAR-T cell Immunotherapy to Attack Solid Tumors
Guru Focus
Thu, 08/25/22 - 07:58 pm
Regen Biopharma
solid tumors
CAR-T
cell therapy cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »